{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:56:12Z","timestamp":1791323772844,"version":"4.3.1"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.phrs.2025.107585","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:25:27Z","timestamp":1736209527000},"page":"107585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Do cytokines play a role in the transition from acute to chronic musculoskeletal pain?"],"prefix":"10.1016","volume":"212","author":[{"given":"Andrea","family":"Ebersberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4708-2221","authenticated-orcid":false,"given":"Hans-Georg","family":"Schaible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"issue":"10289","key":"10.1016\/j.phrs.2025.107585_bib2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.phrs.2025.107585_bib3","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","article-title":"Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system","volume":"162","author":"Kosek","year":"2021","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.phrs.2025.107585_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2018.07.040","article-title":"The analgesic potential of cytokine neutralization with biologicals","volume":"835","author":"Ebersberger","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107585_bib6","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3389\/fimmu.2019.03061","article-title":"Neuraxial cytokines in pain states","volume":"10","author":"Goncalves Dos Santos","year":"2019","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib7","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221687","article-title":"Immune drivers of physiological and pathological pain","volume":"221","author":"Jain","year":"2024","journal-title":"J. Exp. Med"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2009.09.033","article-title":"Current challenges in glia-pain biology","volume":"64","author":"McMahon","year":"2009","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","article-title":"Nociceptive neurons detect cytokines in arthritis","volume":"16","author":"Schaible","year":"2014","journal-title":"Arthritis Res Ther."},{"issue":"11","key":"10.1016\/j.phrs.2025.107585_bib10","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1111\/jnc.15742","article-title":"Spinal pain processing in arthritis: neuron and glia (inter)actions","volume":"168","author":"Schaible","year":"2024","journal-title":"J. Neurochem"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","article-title":"The Jak\/STAT pathway: a focus on pain in rheumatoid arthritis","volume":"51","author":"Simon","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib12","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/BOT.0000000000001430","article-title":"F. Orthopaedic trauma association musculoskeletal pain task, clinical practice guidelines for pain management in acute musculoskeletal injury","volume":"33","author":"Hsu","year":"2019","journal-title":"J. Orthop. Trauma"},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ejp.796","article-title":"Incidence and prognostic factors of chronic pain after isolated musculoskeletal extremity injury","volume":"20","author":"Pierik","year":"2016","journal-title":"Eur. J. Pain."},{"issue":"11","key":"10.1016\/j.phrs.2025.107585_bib14","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.pain.2014.08.026","article-title":"Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain","volume":"155","author":"Chartier","year":"2014","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11914-018-0446-8","article-title":"New insights in understanding and treating bone fracture pain","volume":"16","author":"Mitchell","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2018-100036","article-title":"Acute postoperative pain is an independent predictor of chronic postsurgical pain following total knee arthroplasty at 6 months: a prospective cohort study","volume":"44","author":"Buvanendran","year":"2019","journal-title":"Reg. Anesth. Pain. Med"},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.joca.2016.12.013","article-title":"The association of pre-operative body pain diagram scores with pain outcomes following total knee arthroplasty","volume":"25","author":"Dave","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.phrs.2025.107585_bib18","first-page":"E729","article-title":"Predictive factors of chronic post-surgical pain at 6 months following knee replacement: influence of postoperative pain trajectory and genetics","author":"Thomazeau","year":"2016","journal-title":"Pain. Physician 19(5"},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025091","article-title":"Preoperative predictors of poor acute postoperative pain control: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2019","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AJP.0000000000000861","article-title":"Plasma Concentrations of select inflammatory cytokines predicts pain intensity 48 hours post-shoulder muscle injury","volume":"36","author":"Hedderson","year":"2020","journal-title":"Clin. J. Pain."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/rapm-2021-102953","article-title":"Identification of biological risk factors for persistent postoperative pain after total knee arthroplasty","volume":"47","author":"Sideris","year":"2022","journal-title":"Reg. Anesth. Pain. Med"},{"issue":"9","key":"10.1016\/j.phrs.2025.107585_bib22","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1097\/j.pain.0000000000002938","article-title":"Predicting chronic postsurgical pain: current evidence and a novel program to develop predictive biomarker signatures","volume":"164","author":"Sluka","year":"2023","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14789450.2020.1797499","article-title":"Proteomic studies of common chronic pain conditions - a systematic review and associated network analyses","volume":"17","author":"Gerdle","year":"2020","journal-title":"Expert Rev. Proteom."},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib24","first-page":"557","article-title":"Cerebrospinal fluid cytokine levels after surgery with spinal or general anesthesia","volume":"24","author":"Yeager","year":"1999","journal-title":"Reg. Anesth. Pain. Med"},{"issue":"12","key":"10.1016\/j.phrs.2025.107585_bib25","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.spinee.2018.07.023","article-title":"Elevated inflammatory cytokine expression in CSF from patients with symptomatic thoracic disc herniation correlates with increased pain scores","volume":"18","author":"Andrade","year":"2018","journal-title":"Spine J."},{"key":"10.1016\/j.phrs.2025.107585_bib26","doi-asserted-by":"crossref","unstructured":"V. Chidambaran, Q. Duan, V. Pilipenko, S.M. Glynn, A. Sproles, L.J. Martin, M.J. Lacagnina, C.D. King, L. Ding, The Role of Cytokines in Acute and Chronic Postsurgical Pain in Pediatric Patients after Major Musculoskeletal Surgeries, medRxiv (2024).","DOI":"10.1101\/2024.03.27.24304974"},{"issue":"11","key":"10.1016\/j.phrs.2025.107585_bib27","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jor.24398","article-title":"Chronic, active inflammation in patients with failed total knee replacements undergoing revision surgery","volume":"37","author":"Paish","year":"2019","journal-title":"J. Orthop. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/papr.13051","article-title":"Decreased pain sensitivity and alterations of cerebrospinal fluid and plasma inflammatory mediators after total hip arthroplasty in patients with disabling osteoarthritis","volume":"22","author":"Bjurstrom","year":"2022","journal-title":"Pain. Pr."},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14789450.2017.1366859","article-title":"Molecular signature of complex regional pain syndrome (CRPS) and its analysis","volume":"14","author":"K\u00f6nig","year":"2017","journal-title":"Expert Rev. Proteom."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrneurol.2018.20","article-title":"Complex regional pain syndrome - phenotypic characteristics and potential biomarkers","volume":"14","author":"Birklein","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10286-019-00612-0","article-title":"Complex regional pain syndrome: a focus on the autonomic nervous system","volume":"29","author":"Knudsen","year":"2019","journal-title":"Clin. Auton. Res"},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib32","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.pain.2013.06.039","article-title":"Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months","volume":"154","author":"Lenz","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib33","doi-asserted-by":"crossref","first-page":"28398","DOI":"10.1155\/MI\/2006\/28398","article-title":"Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1","volume":"2006","author":"Heijmans-Antonissen","year":"2006","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpain.2014.01.490","article-title":"Activation of cutaneous immune responses in complex regional pain syndrome","volume":"15","author":"Birklein","year":"2014","journal-title":"J. Pain."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107585_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pain.2007.07.031","article-title":"Differential expression patterns of cytokines in complex regional pain syndrome","volume":"132","author":"Uceyler","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2025.107585_bib36","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2147\/JPR.S423733","article-title":"The role of neuroinflammation in complex regional pain syndrome: a comprehensive review","volume":"16","author":"Wen","year":"2023","journal-title":"J. Pain. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpain.2011.10.003","article-title":"Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome","volume":"13","author":"Alexander","year":"2012","journal-title":"J. Pain."},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/aas.12465","article-title":"Inflammation in cold complex regional pain syndrome","volume":"59","author":"Dirckx","year":"2015","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2008.03.081","article-title":"Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS)","volume":"437","author":"Birklein","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e31827b1aa1","article-title":"Inflammation in complex regional pain syndrome: a systematic review and meta-analysis","volume":"80","author":"Parkitny","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbi.2006.10.009","article-title":"Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome","volume":"21","author":"Alexander","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.phrs.2025.107585_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/papr.12078","article-title":"Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNF-alpha chimeric monoclonal antibody infliximab in complex regional pain syndrome","volume":"13","author":"Dirckx","year":"2013","journal-title":"Pain. Pr."},{"key":"10.1016\/j.phrs.2025.107585_bib43","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2147\/JPR.S408858","article-title":"Effectiveness of infliximab in patients with complex regional pain syndrome: a case series","volume":"16","author":"van den Berg","year":"2023","journal-title":"J. Pain. Res"},{"issue":"8","key":"10.1016\/j.phrs.2025.107585_bib44","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2217\/pmt-2022-0046","article-title":"Clinical practice guidelines for the management of patients with complex regional pain syndrome: a systematic appraisal using the AGREE II instrument","volume":"12","author":"Javed","year":"2022","journal-title":"Pain. Manag"},{"issue":"10416","key":"10.1016\/j.phrs.2025.107585_bib45","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-023-01121-w","article-title":"Multimorbidity in rheumatoid arthritis: literature review and future directions","volume":"26","author":"Katz","year":"2024","journal-title":"Curr. Rheuma Rep."},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib47","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/annrheumdis-2014-205522","article-title":"Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI","volume":"74","author":"van Steenbergen","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","article-title":"The role of TNF-alpha in rheumatoid arthritis: a focus on regulatory T cells","volume":"2","author":"Farrugia","year":"2016","journal-title":"J. Clin. Transl. Res"},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00296-008-0688-3","article-title":"Circulating E-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis","volume":"29","author":"Corona-Sanchez","year":"2009","journal-title":"Rheuma Int"},{"issue":"9","key":"10.1016\/j.phrs.2025.107585_bib50","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/acr.24264","article-title":"Pain over two years after start of biologic versus conventional combination treatment in early rheumatoid arthritis: results from a swedish randomized controlled trial","volume":"73","author":"Olofsson","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.phrs.2025.107585_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/OARRR.S218448","article-title":"A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance","volume":"11","author":"Hafstrom","year":"2019","journal-title":"Open Access Rheuma"},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib52","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/ard-2023-225414","article-title":"Predictors for severe persisting pain in rheumatoid arthritis are associated with pain origin and appraisal of pain","volume":"83","author":"Baerwald","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/03009742.2021.1944304","article-title":"Pain in rheumatoid arthritis: a seven-year follow-up study of pain distribution and factors associated with transition from and to chronic widespread pain","volume":"51","author":"Andersson","year":"2022","journal-title":"Scand. J. Rheuma"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13075-015-0761-8","article-title":"Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis","volume":"17","author":"Koop","year":"2015","journal-title":"Arthritis Res Ther."},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib55","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/acr.21723","article-title":"Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study","volume":"64","author":"McWilliams","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-019-04749-1","article-title":"The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases","volume":"39","author":"Guler","year":"2020","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.phrs.2025.107585_bib57","first-page":"803","article-title":"Neuropathic pain and cytokines: current perspectives","volume":"6","author":"Clark","year":"2013","journal-title":"J. Pain. Res"},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4161\/bbug.1.4.12105","article-title":"Biologic TNFalpha-inhibitors that cross the human blood-brain barrier","volume":"1","author":"Pardridge","year":"2010","journal-title":"Bioeng. Bugs"},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40259-017-0248-z","article-title":"Delivery of biologics across the blood-brain barrier with molecular trojan horse technology","volume":"31","author":"Pardridge","year":"2017","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/25785826.2023.2235734","article-title":"Pathophysiology and stratification of treatment-resistant rheumatoid arthritis","volume":"47","author":"Yamada","year":"2024","journal-title":"Immunol. Med"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10787-022-00995-z","article-title":"Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis","volume":"30","author":"Salaffi","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib63","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/annrheumdis-2022-222586","article-title":"Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration","volume":"81","author":"Lauper","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009742.2017.1390605","article-title":"Secukinumab after anti-tumour necrosis factor-alpha therapy: a phase III study in active rheumatoid arthritis","volume":"47","author":"Dokoupilova","year":"2018","journal-title":"Scand. J. Rheuma"},{"key":"10.1016\/j.phrs.2025.107585_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156381","article-title":"Wnt5a: a promising therapeutic target for inflammation, especially rheumatoid arthritis","volume":"172","author":"Huang","year":"2023","journal-title":"Cytokine"},{"issue":"35","key":"10.1016\/j.phrs.2025.107585_bib66","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1523\/JNEUROSCI.2942-19.2020","article-title":"Spinal Wnt5a plays a key role in spinal dendritic spine remodeling in neuropathic and inflammatory pain models and in the proalgesic effects of peripheral Wnt3a","volume":"40","author":"Simonetti","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107585_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcot.2021.101729","article-title":"Anti-cyclic citrullinated peptide antibody (ACPA) and rheumatoid arthritis: clinical relevance","volume":"24","author":"Iyengar","year":"2022","journal-title":"J. Clin. Orthop. Trauma"},{"key":"10.1016\/j.phrs.2025.107585_bib68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-407708-9.00003-0","article-title":"Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond","volume":"118","author":"Klareskog","year":"2013","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.phrs.2025.107585_bib70","article-title":"Anti-citrullinated protein antibody generation, pathogenesis, clinical application, and prospects","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib71","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2025.107585_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081778","article-title":"Antibodies to citrullinated proteins (ACPA) associate with markers of osteoclast activation and bone destruction in the bone marrow of patients with rheumatoid arthritis","volume":"10","author":"Kurowska","year":"2021","journal-title":"J. Clin. Med"},{"issue":"11","key":"10.1016\/j.phrs.2025.107585_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260254","article-title":"Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis","volume":"16","author":"Matsumoto","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib74","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41598-023-32428-4","article-title":"Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity","volume":"13","author":"Cunningham","year":"2023","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib75","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheuma"},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030614","article-title":"The link between inflammaging and degenerative joint diseases","volume":"20","author":"Rezus","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/annrheumdis-2011-201047","article-title":"Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study","volume":"72","author":"Stannus","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"24","key":"10.1016\/j.phrs.2025.107585_bib78","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1016\/j.cell.2021.11.003","article-title":"Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations","volume":"184","author":"Boer","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107585_bib79","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fnmol.2017.00349","article-title":"Mechanisms of osteoarthritic pain. studies in humans and experimental models","volume":"10","author":"Eitner","year":"2017","journal-title":"Front Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2023.100433","article-title":"Pain-phenotyping in osteoarthritis: current concepts, evidence, and considerations towards a comprehensive framework for assessment and treatment","volume":"6","author":"Saxer","year":"2024","journal-title":"Osteoarthr. Cartil. Open"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.0000000000000011","article-title":"Identifying specific profiles in patients with different degrees of painful knee osteoarthritis based on serological biochemical and mechanistic pain biomarkers: a diagnostic approach based on cluster analysis","volume":"156","author":"Egsgaard","year":"2015","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib82","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.joca.2020.01.016","article-title":"Identifying effector molecules, cells, and cytokines of innate immunity in OA","volume":"28","author":"van den Bosch","year":"2020","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib83","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.joca.2023.06.005","article-title":"Fundamentals of osteoarthritis: inflammatory mediators in osteoarthritis","volume":"31","author":"De Roover","year":"2023","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib84","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.joca.2023.12.005","article-title":"Inflammation in osteoarthritis: Our view on its presence and involvement in disease development over the years","volume":"32","author":"van den Bosch","year":"2024","journal-title":"Osteoarthr. Cartil."},{"issue":"7","key":"10.1016\/j.phrs.2025.107585_bib85","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrrheum.2013.44","article-title":"Biologic agents in osteoarthritis: hopes and disappointments","volume":"9","author":"Chevalier","year":"2013","journal-title":"Nat. Rev. Rheuma"},{"issue":"11","key":"10.1016\/j.phrs.2025.107585_bib86","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","article-title":"Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions","volume":"53","author":"Cho","year":"2021","journal-title":"Exp. Mol. Med"},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib87","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14728214.2018.1547706","article-title":"Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics","volume":"23","author":"Oo","year":"2018","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"2","key":"10.1016\/j.phrs.2025.107585_bib88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.34646","article-title":"Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization","volume":"65","author":"Finan","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib89","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11914-018-0477-1","article-title":"Mechanisms of osteoarthritis (OA) pain","volume":"16","author":"O'Neill","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib90","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41413-021-00147-z","article-title":"Subchondral bone microenvironment in osteoarthritis and pain","volume":"9","author":"Hu","year":"2021","journal-title":"Bone Res"},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib91","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.joca.2019.12.002","article-title":"Association between bone marrow lesions & synovitis and symptoms in symptomatic knee osteoarthritis","volume":"28","author":"Perry","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.phrs.2025.107585_bib92","article-title":"Bone marrow lesions in osteoarthritis: from basic science to clinical implications","volume":"18","author":"Shi","year":"2023","journal-title":"Bone Rep."},{"issue":"12","key":"10.1016\/j.phrs.2025.107585_bib93","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10067-009-1258-0","article-title":"Detection of pain-related molecules in the subchondral bone of osteoarthritic knees","volume":"28","author":"Ogino","year":"2009","journal-title":"Clin. Rheuma"},{"issue":"2","key":"10.1016\/j.phrs.2025.107585_bib94","first-page":"337","article-title":"Inflammatory biomarkers in patients with painful knee osteoarthritis: exploring the potential link to chronic postoperative pain after total knee arthroplasty-a secondary analysis","volume":"165","author":"Giordano","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2025.107585_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101972","article-title":"Genetics of osteoarthritis","author":"Zhai","year":"2024","journal-title":"Best. Pr. Res Clin. Rheuma"},{"key":"10.1016\/j.phrs.2025.107585_bib96","doi-asserted-by":"crossref","first-page":"1038808","DOI":"10.3389\/fpain.2023.1038808","article-title":"The degeneration-pain relationship in the temporomandibular joint: current understandings and rodent models","volume":"4","author":"Chung","year":"2023","journal-title":"Front Pain. Res (Lausanne)"},{"key":"10.1016\/j.phrs.2025.107585_bib97","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cyto.2015.11.005","article-title":"Cytokine profile in the synovial fluid of patients with temporomandibular joint disorders: a systematic review","volume":"77","author":"Kellesarian","year":"2016","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib98","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/joor.13321","article-title":"Cytokines in temporomandibular joint synovial fluid and tissue in relation to inflammation","volume":"49","author":"Ulmner","year":"2022","journal-title":"J. Oral. Rehabil."},{"key":"10.1016\/j.phrs.2025.107585_bib99","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jdsr.2023.08.006","article-title":"The role of inflammatory markers in temporomandibular myalgia: a systematic review","volume":"59","author":"Farre-Guasch","year":"2023","journal-title":"Jpn Dent. Sci. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2025.107585_bib100","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.pain.2011.09.005","article-title":"Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness","volume":"152","author":"Slade","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.phrs.2025.107585_bib101","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","article-title":"Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Collaborators","year":"2023","journal-title":"Lancet Rheuma"},{"issue":"10137","key":"10.1016\/j.phrs.2025.107585_bib102","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/S0140-6736(18)30480-X","article-title":"Low back pain series working, what low back pain is and why we need to pay attention","volume":"391","author":"Hartvigsen","year":"2018","journal-title":"Lancet"},{"issue":"10294","key":"10.1016\/j.phrs.2025.107585_bib103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(21)00733-9","article-title":"Low back pain","volume":"398","author":"Knezevic","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib104","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12891-020-3154-3","article-title":"A systematic review of the role of inflammatory biomarkers in acute, subacute and chronic non-specific low back pain","volume":"21","author":"Morris","year":"2020","journal-title":"BMC Musculoskelet. Disord."},{"issue":"5","key":"10.1016\/j.phrs.2025.107585_bib105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/AJP.0000000000000810","article-title":"Association between inflammatory biomarkers and nonspecific low back pain: a systematic review","volume":"36","author":"Lim","year":"2020","journal-title":"Clin. J. Pain."},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib106","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/AJP.0000000000000745","article-title":"Nonspecific Low Back Pain: Inflammatory Profiles of Patients With Acute and Chronic Pain","volume":"35","author":"Teodorczyk-Injeyan","year":"2019","journal-title":"Clin. J. Pain."},{"key":"10.1016\/j.phrs.2025.107585_bib107","doi-asserted-by":"crossref","first-page":"1207666","DOI":"10.3389\/fnint.2023.1207666","article-title":"Urinary TNF-alpha as a potential biomarker for chronic primary low back pain","volume":"17","author":"Gevers-Montoro","year":"2023","journal-title":"Front Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib108","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/nyas.13551","article-title":"Inflammatory biomarkers of low back pain and disc degeneration: a review","volume":"1410","author":"Khan","year":"2017","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"1-3","key":"10.1016\/j.phrs.2025.107585_bib109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-015-8709-2","article-title":"Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders","volume":"63","author":"Weber","year":"2015","journal-title":"Immunol. Res"},{"issue":"10","key":"10.1016\/j.phrs.2025.107585_bib110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.joca.2020.06.009","article-title":"Severity of intervertebral disc herniation regulates cytokine and chemokine levels in patients with chronic radicular back pain","volume":"28","author":"Jacobsen","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.phrs.2025.107585_bib111","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ebiom.2019.04.032","article-title":"Interleukin-8 as a therapeutic target for chronic low back pain: upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model","volume":"43","author":"Krock","year":"2019","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.phrs.2025.107585_bib112","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/pm\/pny214","article-title":"Biologic drugs as analgesics for the management of low back pain and sciatica","volume":"20","author":"Dimitroulas","year":"2019","journal-title":"Pain. Med"},{"issue":"7","key":"10.1016\/j.phrs.2025.107585_bib113","doi-asserted-by":"crossref","DOI":"10.3928\/01477447-20140626-62","article-title":"Th17 cell frequency and IL-17 concentration correlate with pre- and postoperative pain sensation in patients with intervertebral disk degeneration","volume":"37","author":"Zhang","year":"2014","journal-title":"Orthopedics"},{"key":"10.1016\/j.phrs.2025.107585_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111992","article-title":"Research on the role and mechanism of IL-17 in intervertebral disc degeneration","volume":"132","author":"Peng","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.107585_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.857164","article-title":"The role of IL-17-mediated inflammatory processes in the pathogenesis of intervertebral disc degeneration and herniation: a comprehensive review","volume":"10","author":"Suyama","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2025.107585_bib116","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.intimp.2019.04.012","article-title":"PPAR-gamma agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-kappaB signaling pathway","volume":"72","author":"Liu","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.107585_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.622770","article-title":"Clinical trials supporting the role of the IL-17\/IL-23 axis in axial spondyloarthritis","volume":"12","author":"Ceribelli","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/reum.2015.50551","article-title":"Cytokine profiles in axial spondyloarthritis","volume":"53","author":"Madej","year":"2015","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib119","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13075-023-03128-1","article-title":"Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study","volume":"25","author":"Baraliakos","year":"2023","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.phrs.2025.107585_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109486","article-title":"Transglutaminase 2 inhibitors attenuate osteoarthritic degeneration of TMJ-osteoarthritis by suppressing NF-kappaB activation","volume":"114","author":"Li","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib121","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.anes.0000267518.20363.0d","article-title":"A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy","volume":"107","author":"Cohen","year":"2007","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.phrs.2025.107585_bib122","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.33846","article-title":"Reattribution to mind-brain processes and recovery from chronic back pain: a secondary analysis of a randomized clinical trial","volume":"6","author":"Ashar","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.phrs.2025.107585_bib123","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211028001","article-title":"Intervertebral disc therapies for non-specific chronic low back pain: a systematic review and meta-analysis","volume":"13","author":"Daste","year":"2021","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2025.107585_bib124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.semarthrit.2015.05.002","article-title":"Structural and functional brain abnormalities in chronic low back pain: a systematic review","volume":"45","author":"Kregel","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.phrs.2025.107585_bib125","doi-asserted-by":"crossref","first-page":"1206604","DOI":"10.3389\/fnins.2023.1206604","article-title":"Abnormal brain activity in lumbar disc herniation patients with chronic pain is associated with their clinical symptoms","volume":"17","author":"Tang","year":"2023","journal-title":"Front Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1152\/physrev.00040.2019","article-title":"Cellular circuits in the brain and their modulation in acute and chronic pain","volume":"101","author":"Kuner","year":"2021","journal-title":"Physiol. Rev."},{"issue":"Pt 3","key":"10.1016\/j.phrs.2025.107585_bib127","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/brain\/awu377","article-title":"Evidence for brain glial activation in chronic pain patients","volume":"138","author":"Loggia","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib128","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/brain\/awab336","article-title":"Neuroimmune signatures in chronic low back pain subtypes","volume":"145","author":"Alshelh","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"Milligan","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2025.107585_bib130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.phrs.2025.107585_bib131","article-title":"Assessing the potential anti-neuroinflammatory effect of minocycline in chronic low back pain: protocol for a randomized, double-blind, placebo-controlled trial","volume":"126","author":"Morrissey","year":"2023","journal-title":"Conte Clin. Trials"},{"issue":"7","key":"10.1016\/j.phrs.2025.107585_bib132","first-page":"e65","article-title":"Unraveling the neuroimmune interface in chronic pain-the association between cytokines in the cerebrospinal fluid and pain in patients with lumbar disk herniation or degenerative disk disease","volume":"165","author":"Rosenstrom","year":"2024","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib133","first-page":"157","article-title":"Cytokines in cerebrospinal fluid and chronic pain in humans: past, present, and future","volume":"31","author":"Rosenstrom","year":"2024","journal-title":"Neuroimmunomodulation"},{"issue":"10137","key":"10.1016\/j.phrs.2025.107585_bib134","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/S0140-6736(18)30489-6","article-title":"Prevention and treatment of low back pain: evidence, challenges, and promising directions","volume":"391","author":"Foster","year":"2018","journal-title":"Lancet"},{"issue":"644","key":"10.1016\/j.phrs.2025.107585_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj9954","article-title":"Acute inflammatory response via neutrophil activation protects against the development of chronic pain","volume":"14","author":"Parisien","year":"2022","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107585_bib136","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JPR.S128508","article-title":"Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma","volume":"10","author":"Backryd","year":"2017","journal-title":"J. Pain. Res"},{"key":"10.1016\/j.phrs.2025.107585_bib137","doi-asserted-by":"crossref","first-page":"3985154","DOI":"10.1155\/2018\/3985154","article-title":"Plasma cytokine levels in fibromyalgia and their response to 15 weeks of progressive resistance exercise or relaxation therapy","volume":"2018","author":"Ernberg","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107585_bib138","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5606\/ArchRheumatol.2019.6733","article-title":"Pro-inflammatory cytokines and oxidized low-density-lipoprotein in patients with fibromyalgia","volume":"34","author":"Kutu","year":"2019","journal-title":"Arch. Rheuma"},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib139","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/s12891-023-06744-9","article-title":"Evidence for an association of serum microanalytes and myofascial pain syndrome","volume":"24","author":"Pradeep","year":"2023","journal-title":"BMC Musculoskelet. Disord."},{"issue":"17","key":"10.1016\/j.phrs.2025.107585_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174231","article-title":"Machine learning to understand the immune-inflammatory pathways in fibromyalgia","volume":"20","author":"Andres-Rodriguez","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107585_bib141","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: cytokines in fibromyalgia syndrome","volume":"12","author":"Uceyler","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.phrs.2025.107585_bib142","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2015.02.002","article-title":"Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain--interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritis","volume":"280","author":"Kosek","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib143","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10787-023-01216-x","article-title":"Microglia polarization in nociplastic pain: mechanisms and perspectives","volume":"31","author":"Atta","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11916-008-0031-4","article-title":"Status of immune mediators in fibromyalgia","volume":"12","author":"Gur","year":"2008","journal-title":"Curr. Pain. Headache Rep."},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40744-024-00656-3","article-title":"Long-term etanercept response for patients with radiographic axial spondyloarthritis based on achievement of early, intermediate, or late responses during index studies","volume":"11","author":"Baraliakos","year":"2024","journal-title":"Rheuma Ther."},{"issue":"2","key":"10.1016\/j.phrs.2025.107585_bib146","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40744-021-00418-5","article-title":"Effectiveness of etanercept in rheumatoid arthritis: real-world data from the german non-interventional study ADEQUATE witH Focus on Treat-to-target and Patient-reported Outcomes","volume":"9","author":"Feist","year":"2022","journal-title":"Rheuma Ther."},{"issue":"4","key":"10.1016\/j.phrs.2025.107585_bib147","doi-asserted-by":"crossref","DOI":"10.1186\/ar3430","article-title":"A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"10.1016\/j.phrs.2025.107585_bib148","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A phase II trial of lutikizumab, an anti-interleukin-1alpha\/beta dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.phrs.2025.107585_bib149","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","article-title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1alpha and anti-interleukin-1beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2025.107585_bib150","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10494","article-title":"Dual biologic therapy in patients with rheumatoid arthritis and psoriatic arthritis","volume":"14","author":"Furer","year":"2023","journal-title":"Rambam Maimonides Med J."},{"issue":"38","key":"10.1016\/j.phrs.2025.107585_bib151","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1523\/JNEUROSCI.4159-15.2016","article-title":"Involvement of spinal IL-6 trans-signaling in the induction of hyperexcitability of deep dorsal horn neurons by spinal tumor necrosis factor-alpha","volume":"36","author":"K\u00f6nig","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107585_bib152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2024.11.021","article-title":"Antinociceptive interactions between excitatory interferon-gamma and interleukin-17 in sensory neurons","volume":"124","author":"Natura","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107585_bib153","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11420-005-0133-z","article-title":"Combination therapy for rheumatoid arthritis in the era of biologicals","volume":"2","author":"Gibofsky","year":"2006","journal-title":"HSS J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:27:44Z","timestamp":1738895264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":153,"alternative-id":["S1043661825000106"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107585","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do cytokines play a role in the transition from acute to chronic musculoskeletal pain?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107585"}}